Sorensen PH et al. demonstrated, in 171 pediatric ARMS individuals, that the expression of PAX3/FOXO1 and PAX7/FOXO1 translocations induce a significantly worse outcome compared to patients without them, due to a higher risk for metastatic disease [51]. This evidence concerns the gene FOXO1 and alveolar rhabdomyosarcoma.